RIVIVE
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 May 2022)
What this means for you
This application is over — abandoned 02 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88113597
- Mark type
- Stylized text
- Filed
- 12 Sept 2018
- Published for opposition
- 29 Jan 2019
- Abandoned
- 02 May 2022
- Attorney of record
- Joseph W. Berenato, III
Goods and services
- Class 005 — Pharmaceuticals: Naloxone intranasal spray product
Owner
- Harm Reduction Therapeutics, Inc., Bethesda, MD, US
- Harm Reduction Therapeutics, Inc., Bethesda, MD, US
Prosecution history
- 02 May 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 May 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Sept 2021 — SOU EXTENSION 5 GRANTED
- 22 Sept 2021 — SOU EXTENSION 5 FILED
- 27 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2021 — SOU EXTENSION 4 GRANTED
- 23 Feb 2021 — SOU EXTENSION 4 FILED
- 23 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2020 — SOU EXTENSION 3 GRANTED
- 26 Aug 2020 — SOU EXTENSION 3 FILED
- 26 Aug 2020 — SOU TEAS EXTENSION RECEIVED